Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Vertex Pharmaceuticals
Vertex Pharmaceuticals
In historic decision, FDA approves a CRISPR-based medicine for treatment of sickle cell disease
Stat
Fri, 12/8/23 - 11:36 am
Vertex Pharmaceuticals
FDA
CRISPR
gene editing
Casgevy
sickle cell disease
FDA Could Approve First CRISPR Treatment Today That Might Cure Sickle Cell
Forbes
Fri, 12/8/23 - 09:54 am
Vertex Pharmaceuticals
Casgevy
FDA
CRISPR
sickle cell disease
Where Will Vertex Pharmaceuticals Be in 10 Years?
Motley Fool
Mon, 12/4/23 - 09:31 am
Vertex Pharmaceuticals
cystic fibrosis
exa-cel
sickle cell disease
What to know about the U.K.’s approval of the first CRISPR treatment for diseases
Nature
Fri, 11/17/23 - 10:05 am
UK
CRISPR
gene editing
Casgevy
Vertex Pharmaceuticals
CRISPR Therapeutics
Vertex, CRISPR Win World’s First Approval for CRISPR-Edited Therapy from UK
BioSpace
Thu, 11/16/23 - 10:21 am
CRISPR
gene editing
Vertex Pharmaceuticals
CRISPR Therapeutics
UK
Casgevy
beta thalassemia
Cell & Gene Therapy Space Gears Up for First CRISPR Approval
BioSpace
Mon, 11/13/23 - 11:48 am
CRISPR
gene therapy
cell therapy
sickle cell disease
exa-cel
Vertex Pharmaceuticals
CRISPR Therapeutics
Bluebird won't play off Vertex in deciding price for its lovo-cel gene therapy, exec says
Fierce Pharma
Tue, 11/7/23 - 11:02 pm
Bluebird Bio
Vertex Pharmaceuticals
exa-cel
lovo-cel
sickle cell disease
drug pricing
As Vertex preps for exa-cel launch, exec touts 'very large' opportunity but tempers early expectations
Fierce Pharma
Tue, 11/7/23 - 11:47 am
Vertex Pharmaceuticals
CRISPR
gene editing
FDA
exa-cel
FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study
Yahoo/Reuters
Tue, 10/31/23 - 09:23 pm
Vertex Pharmaceuticals
CRISPR Therapeutics
FDA
gene therapy
exa-cel
Tracking the FDA’s meeting on Vertex, CRISPR’s sickle cell therapy
BioPharma Dive
Tue, 10/31/23 - 10:13 am
FDA
Vertex Pharmaceuticals
CRISPR
sickle cell disease
exa-cel
FDA Flags Off-Target Effects of Vertex, CRISPR’s Sickle Cell Therapy Ahead of Adcomm
BioSpace
Mon, 10/30/23 - 08:09 pm
Vertex Pharmaceuticals
exa-cel
CRISPR
sickle cell disease
FDA
Vertex gearing up for launch as sickle cell therapy review advances
BioPharma Dive
Thu, 10/26/23 - 10:42 pm
Vertex Pharmaceuticals
sickle cell disease
exa-cel
Vertex Presents Positive, Updated VX-880 Results From Ongoing Phase 1/2 Study in Type 1 Diabetes at the European Association for the Study of Diabetes 59th Annual Meeting
Businesswire
Tue, 10/3/23 - 07:32 pm
Vertex Pharmaceuticals
VX-880
clinical trials
type 1 diabetes
5 FDA decisions to watch in the fourth quarter
BioPharma Dive
Mon, 10/2/23 - 12:00 pm
FDA
Alnylam
Onpattro
ATTR amyloidosis
Vertex Pharmaceuticals
CRISPR Therapeutics
exa-cel
Bluebird Bio
Zynteglo
sickle cell disease
Bristol Myers Squibb
2seventy bio
Abecma
Multiple Myeloma
Amgen
Lumakras
non-small cell lung cancer
Pfizer
estrasimod
ulcerative colitis
Vertex gets in on GPCR game, paying Septerna $47M for undisclosed program
Fierce Biotech
Tue, 09/12/23 - 10:42 am
Vertex Pharmaceuticals
GPCRs
Septerna
Promising Vertex Pain Med Points to New Era for Analgesics
BioSpace
Mon, 08/28/23 - 11:45 am
Vertex Pharmaceuticals
VX-548
NEJM
painkillers
post-surgical pain
Aiming to be biggest biotech in Boston, Vertex plots 500-person cell, gene therapy R&D center
Fierce Biotech
Fri, 08/4/23 - 12:15 pm
Vertex Pharmaceuticals
cell therapy
gene therapy
R&D
Boston
First-ever CRISPR-CAS9 therapy, exa-cel, shows promising results
Clinical Trials Arena
Thu, 08/3/23 - 06:28 pm
Vertex Pharmaceuticals
exa-cel
CRISPR
beta thalassemia
Vertex Pharma raises full-year revenue forecast on cystic fibrosis treatment strength
Yahoo/Reuters
Wed, 08/2/23 - 10:18 am
Vertex Pharmaceuticals
cystic fibrosis
earnings
U.S. watchdog lifts price estimate for Bluebird, Vertex/CRISPR gene therapies to $2.1 million
Reuters
Fri, 07/14/23 - 10:07 am
ICER
gene therapy
Vertex Pharmaceuticals
CRISPR Therapeutics
Bluebird Bio
drug pricing
sickle cell disease
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »